Search hospitals > California > Whittier
Innovative Clinical Research Institute
Claim this profileWhittier, California 90603
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Lymphoma
Conducts research for Cancer
123 reported clinical trials
9 medical researchers
Summary
Innovative Clinical Research Institute is a medical facility located in Whittier, California. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Lymphoma, Cancer and other specialties. Innovative Clinical Research Institute is involved with conducting 123 clinical trials across 105 conditions. There are 9 research doctors associated with this hospital, such as Omkar S Marathe, Richy Agajanian, MD, Amitabha Mazumder, and Paul La Porte.Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Top PIs
Omkar S MaratheThe Oncology Institute of Hope and Innovation3 years of reported clinical research
Studies Colorectal Cancer
Studies Non-Small Cell Lung Cancer
18 reported clinical trials
31 drugs studied
Richy Agajanian, MDInnovative Clinical Research Institute8 years of reported clinical research
Studies Lymphoma
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
20 drugs studied
Amitabha MazumderThe Oncology Institute of Hope and Innovation5 years of reported clinical research
Studies Lymphoma
Studies Multiple Myeloma
9 reported clinical trials
19 drugs studied
Paul La PorteGSK Investigational Site3 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Breast Cancer
10 reported clinical trials
18 drugs studied
Clinical Trials running at Innovative Clinical Research Institute
Non-Small Cell Lung Cancer
Breast Cancer
Lung Cancer
Solid Tumors
Tumors
Follicular Lymphoma
Lymphoma
Polycythemia Vera
Primary Myelofibrosis
Myelofibrosis
Inupadenant + Chemotherapy
for Non-Small Cell Lung Cancer
This trial tests a new drug, inupadenant, combined with standard chemotherapy drugs in lung cancer patients who did not respond to their first treatment. The goal is to see if this combination works better than the standard treatment alone.
Recruiting2 awards Phase 27 criteria
HBI-2438
for Cancer with KRAS G12C Mutation
This trial tests HBI-2438, an oral drug for patients with advanced solid tumors having the KRAS G12C mutation. The drug aims to stop cancer growth by blocking the faulty gene. Related drugs, Adagrasib and Sotorasib, have shown effectiveness in treating similar conditions.
Recruiting1 award Phase 16 criteria
CAB-AXL-ADC + PD-1 Inhibitor
for Lung Cancer
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in NSCLC
Recruiting1 award Phase 27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Innovative Clinical Research Institute?
Innovative Clinical Research Institute is a medical facility located in Whittier, California. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Lymphoma, Cancer and other specialties. Innovative Clinical Research Institute is involved with conducting 123 clinical trials across 105 conditions. There are 9 research doctors associated with this hospital, such as Omkar S Marathe, Richy Agajanian, MD, Amitabha Mazumder, and Paul La Porte.